Martin Nicklasson
chairman
management
Orexo
Sweden
Biography
M.Sc. Pharm. PhD and Associate Professor at the Faculty of Pharmacy, Uppsala University. Other appointments: Chairman of the Board of Zealand Pharma A/S and Kymab Group Ltd. Board member of Basilea Pharmaceutica Ltd., and Biocrine AB. Member of the Royal Academy of Engineering Sciences (IVA).
Research Interest
development within AstraZeneca Ltd., and CEO of AstraZeneca Sweden AB, CEO of Astra Hässle AB and responsible for R&D within KABI. Holds 10,000 shares and stock options entitled to 162,916 shares, as of December 31 2016.
